{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:01:38Z","timestamp":1791144098674,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12977-015-0151-y","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T09:45:29Z","timestamp":1429868729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Fabrizio","family":"Ensoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Cafaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casabianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tripiciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Francavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orietta","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Sgadari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R Pavone","family":"Cossut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Arancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Sernicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T","family":"Maggiorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paniccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Lazzarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sighinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Palamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino","family":"Angarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito S","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Monini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ensoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"151_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/imr.12065","volume":"254","author":"NR Klatt","year":"2013","unstructured":"Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev. 2013;254:326\u201342.","journal-title":"Immunol Rev"},{"key":"151_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/aid.2011.0032","volume":"28","author":"CG Tsiara","year":"2012","unstructured":"Tsiara CG, Nikolopoulos GK, Bagos PG, Goujard C, Katzenstein TL, Minga AK, et al. Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis. AIDS Res Hum Retroviruses. 2012;28:366\u201373.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"151_CR3","doi-asserted-by":"publisher","first-page":"a3172","DOI":"10.1136\/bmj.a3172","volume":"338","author":"SG Deeks","year":"2009","unstructured":"Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.","journal-title":"BMJ"},{"key":"151_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/path.2276","volume":"214","author":"V Appay","year":"2008","unstructured":"Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol. 2008;214:231\u201341.","journal-title":"J Pathol"},{"key":"151_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/157016208785861195","volume":"6","author":"A Alexaki","year":"2008","unstructured":"Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res. 2008;6:388\u2013400.","journal-title":"Curr HIV Res"},{"key":"151_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature10347","volume":"477","author":"A Sigal","year":"2011","unstructured":"Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, et al. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 2011;477:95\u20138.","journal-title":"Nature"},{"key":"151_CR7","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1128\/JVI.76.20.10099-10108.2002","volume":"76","author":"LG Kostrikis","year":"2002","unstructured":"Kostrikis LG, Touloumi G, Karanicolas R, Pantazis N, Anastassopoulou C, Karafoulidou A, et al. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol. 2002;76:10099\u2013108.","journal-title":"J Virol"},{"key":"151_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/157016208784325010","volume":"6","author":"E Nicastri","year":"2008","unstructured":"Nicastri E, Palmisano L, Sarmati L, D\u2019ettorre G, Parisi S, Andreotti M, et al. HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp\/mL) during differential antiretroviral regimens. Curr HIV Res. 2008;6:261\u20136.","journal-title":"Curr HIV Res"},{"key":"151_CR9","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/S0140-6736(13)60104-X","volume":"381","author":"C Katlama","year":"2013","unstructured":"Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013;381:2109\u201317.","journal-title":"Lancet"},{"key":"151_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1086\/343050","volume":"35","author":"H Drechsler","year":"2002","unstructured":"Drechsler H, Powderly WG. Switching effective antiretroviral therapy: a review. Clin Infect Dis. 2002;35:1219\u201330.","journal-title":"Clin Infect Dis"},{"key":"151_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350901400109","volume":"14","author":"JE McKinnon","year":"2009","unstructured":"McKinnon JE, Mellors JW, Swindells S. Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Antivir Ther. 2009;14:1\u201312.","journal-title":"Antivir Ther"},{"key":"151_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","volume":"376","author":"PA Volberding","year":"2010","unstructured":"Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376:49\u201362.","journal-title":"Lancet"},{"key":"151_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2005.06.006","volume":"122","author":"LS Weinberger","year":"2005","unstructured":"Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell. 2005;122:169\u201382.","journal-title":"Cell"},{"key":"151_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/345084a0","volume":"345","author":"B Ensoli","year":"1990","unstructured":"Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 1990;345:84\u20136.","journal-title":"Nature"},{"key":"151_CR15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.67.1.277-287.1993","volume":"67","author":"B Ensoli","year":"1993","unstructured":"Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol. 1993;67:277\u201387.","journal-title":"J Virol"},{"key":"151_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/371674a0","volume":"371","author":"B Ensoli","year":"1994","unstructured":"Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994;371:674\u201380.","journal-title":"Nature"},{"key":"151_CR17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/00002030-199712000-00006","volume":"11","author":"HC Chang","year":"1997","unstructured":"Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS. 1997;11:1421\u201331.","journal-title":"AIDS"},{"key":"151_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/emboj.2010.32","volume":"29","author":"F Rayne","year":"2010","unstructured":"Rayne F, Debaisieux S, Yezid H, Lin YL, Mettling C, Konate K, et al. Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J. 2010;29:1348\u201362.","journal-title":"EMBO J"},{"key":"151_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","volume":"275","author":"M Ott","year":"1997","unstructured":"Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, et al. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science. 1997;275:1481\u20135.","journal-title":"Science"},{"key":"151_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1061548","volume":"293","author":"Y Wu","year":"2001","unstructured":"Wu Y, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science. 2001;293:1503\u20136.","journal-title":"Science"},{"key":"151_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/187152612798994939","volume":"12","author":"S Mediouni","year":"2012","unstructured":"Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H, et al. Antiretroviral therapy does not block the secretion of the human immunodeficiency virus Tat protein. Infect Disord Drug Targets. 2012;12:81\u20136.","journal-title":"Infect Disord Drug Targets"},{"key":"151_CR22","doi-asserted-by":"publisher","first-page":"e13540","DOI":"10.1371\/journal.pone.0013540","volume":"5","author":"B Ensoli","year":"2010","unstructured":"Ensoli B, Bellino S, Tripiciano A, Longo O, Francavilla V, Marcotullio S, et al. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. PLoS ONE. 2010;5:e13540.","journal-title":"PLoS ONE"},{"key":"151_CR23","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1073\/pnas.1308673110","volume":"110","author":"TP Johnson","year":"2013","unstructured":"Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, et al. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci USA. 2013;110:13588\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"151_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4049\/jimmunol.168.1.197","volume":"168","author":"E Fanales-Belasio","year":"2002","unstructured":"Fanales-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A, et al. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J Immunol. 2002;168:197\u2013206.","journal-title":"J Immunol"},{"key":"151_CR25","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.4049\/jimmunol.173.6.3838","volume":"173","author":"R Gavioli","year":"2004","unstructured":"Gavioli R, Gallerani E, Fortini C, Fabris M, Bottoni A, Canella A, et al. HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J Immunol. 2004;173:3838\u201343.","journal-title":"J Immunol"},{"key":"151_CR26","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1097\/QAD.0b013e32831392d4","volume":"22","author":"B Ensoli","year":"2008","unstructured":"Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, et al. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein. AIDS. 2008;22:2207\u20139.","journal-title":"AIDS"},{"key":"151_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.vaccine.2009.10.038","volume":"28","author":"B Ensoli","year":"2009","unstructured":"Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, et al. The preventive phase I trial with the HIV-1 Tat-based vaccine. Vaccine. 2009;28:371\u20138.","journal-title":"Vaccine"},{"key":"151_CR28","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1016\/j.vaccine.2009.01.090","volume":"27","author":"O Longo","year":"2009","unstructured":"Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine. 2009;27:3306\u201312.","journal-title":"Vaccine"},{"key":"151_CR29","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1128\/JVI.72.11.8952-8960.1998","volume":"72","author":"L Huang","year":"1998","unstructured":"Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol. 1998;72:8952\u201360.","journal-title":"J Virol"},{"key":"151_CR30","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.1073\/pnas.94.15.8116","volume":"94","author":"CJ Li","year":"1997","unstructured":"Li CJ, Ueda Y, Shi B, Borodyansky L, Huang L, Li YZ, et al. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc Natl Acad Sci USA. 1997;94:8116\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"151_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jgm.1381","volume":"11","author":"F Nappi","year":"2009","unstructured":"Nappi F, Chiozzini C, Bordignon V, Borsetti A, Bellino S, Cippitelli M, et al. Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles. J Gene Med. 2009;11:955\u201365.","journal-title":"J Gene Med"},{"key":"151_CR32","doi-asserted-by":"publisher","first-page":"e48781","DOI":"10.1371\/journal.pone.0048781","volume":"7","author":"P Monini","year":"2012","unstructured":"Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, et al. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies. PLoS ONE. 2012;7:e48781.","journal-title":"PLoS ONE"},{"key":"151_CR33","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1128\/JVI.01013-06","volume":"80","author":"E Chertova","year":"2006","unstructured":"Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess Jr JW, et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol. 2006;80:9039\u201352.","journal-title":"J Virol"},{"key":"151_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/9488","volume":"5","author":"A Cafaro","year":"1999","unstructured":"Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med. 1999;5:643\u201350.","journal-title":"Nat Med"},{"key":"151_CR35","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1128\/JVI.00377-10","volume":"84","author":"A Cafaro","year":"2010","unstructured":"Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, et al. Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in Tat-vaccinated mauritian cynomolgus monkeys upon challenge with SHIV89.6P. J Virol. 2010;84:8953\u20138.","journal-title":"J Virol"},{"key":"151_CR36","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1128\/JVI.02888-12","volume":"87","author":"BC Bachler","year":"2013","unstructured":"Bachler BC, Humbert M, Palikuqi B, Siddappa NB, Lakhashe SK, Rasmussen RA, et al. Novel biopanning strategy to identify epitopes associated with vaccine protection. J Virol. 2013;87:4403\u201316.","journal-title":"J Virol"},{"key":"151_CR37","first-page":"165","volume":"4","author":"P Reiss","year":"1991","unstructured":"Reiss P, de Wolf F, Kuiken CL, de Ronde A, Dekker J, Boucher CA, et al. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals. J Acquir Immune Defic Syndr. 1991;4:165\u201372.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"151_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00042560-199512000-00003","volume":"10","author":"MC Re","year":"1995","unstructured":"Re MC, Furlini G, Vignoli M, Ramazzotti E, Roderigo G, De Rosa V, et al. Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:408\u201316.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"151_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0753-3322(02)00327-X","volume":"57","author":"MW Richardson","year":"2003","unstructured":"Richardson MW, Mirchandani J, Duong J, Grimaldo S, Kocieda V, Hendel H, et al. Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. Biomed Pharmacother. 2003;57:4\u201314.","journal-title":"Biomed Pharmacother"},{"key":"151_CR40","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1086\/428909","volume":"191","author":"G Rezza","year":"2005","unstructured":"Rezza G, Fiorelli V, Dorrucci M, Ciccozzi M, Tripiciano A, Scoglio A, et al. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. J Infect Dis. 2005;191:1321\u20134.","journal-title":"J Infect Dis"},{"key":"151_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1742-4690-11-49","volume":"11","author":"S Bellino","year":"2014","unstructured":"Bellino S, Tripiciano A, Picconi O, Francavilla V, Longo O, Sgadari C, et al. The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study. Retrovirology. 2014;11:49.","journal-title":"Retrovirology."},{"key":"151_CR42","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.4049\/jimmunol.0711406","volume":"182","author":"E Fanales-Belasio","year":"2009","unstructured":"Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone Cossut MR, Scoglio A, et al. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. J Immunol. 2009;182:2888\u201397.","journal-title":"J Immunol"},{"key":"151_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.vaccine.2007.11.040","volume":"26","author":"R Gavioli","year":"2008","unstructured":"Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, et al. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS. Vaccine. 2008;26:727\u201337.","journal-title":"Vaccine"},{"key":"151_CR44","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/QAD.0000000000000315","volume":"28","author":"F Sforza","year":"2014","unstructured":"Sforza F, Nicoli F, Gallerani E, Finessi V, Reali E, Cafaro A, et al. HIV-1 Tat affects the programming and functionality of human CD8+ T cells by modulating the expression of T-box transcription factors. AIDS. 2014;28:1729\u201338.","journal-title":"AIDS"},{"key":"151_CR45","doi-asserted-by":"publisher","first-page":"e77746","DOI":"10.1371\/journal.pone.0077746","volume":"8","author":"F Nicoli","year":"2013","unstructured":"Nicoli F, Finessi V, Sicurella M, Rizzotto L, Gallerani E, Destro F, et al. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. PLoS ONE. 2013;8:e77746.","journal-title":"PLoS ONE"},{"key":"151_CR46","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1128\/JVI.01153-09","volume":"83","author":"SA Migueles","year":"2009","unstructured":"Migueles SA, Weeks KA, Nou E, Berkley A, Rood JE, Osborne CM, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876\u201389.","journal-title":"J Virol"},{"key":"151_CR47","doi-asserted-by":"publisher","first-page":"7828","DOI":"10.4049\/jimmunol.0803928","volume":"182","author":"A S\u00e1ez-Ciri\u00f3n","year":"2009","unstructured":"S\u00e1ez-Ciri\u00f3n A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 2009;182:7828\u201337.","journal-title":"J Immunol"},{"key":"151_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","volume":"36","author":"L Shan","year":"2012","unstructured":"Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity. 2012;36:491\u2013501.","journal-title":"Immunity"},{"key":"151_CR49","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1097\/QAD.0000000000000389","volume":"28","author":"C Chiozzini","year":"2014","unstructured":"Chiozzini C, Collacchi B, Nappi F, Bauer T, Arenaccio C, Tripiciano A, et al. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner. AIDS. 2014;28:2189\u2013200.","journal-title":"AIDS"},{"key":"151_CR50","unstructured":"European Medicines Agency. Note for Guidance on Choice of Control Group in Clinical Trials (CPMP\/ICH\/364\/96). January 2001."},{"key":"151_CR51","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/597093","volume":"48","author":"CF Kelley","year":"2009","unstructured":"Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48:787\u201394.","journal-title":"Clin Infect Dis"},{"key":"151_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1086\/595888","volume":"48","author":"GK Robbins","year":"2009","unstructured":"Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, et al. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009;48:350\u201361.","journal-title":"Clin Infect Dis"},{"key":"151_CR53","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/jac\/dkt245","volume":"68","author":"N Rall\u00f3n","year":"2013","unstructured":"Rall\u00f3n N, Sempere-Ortells JM, Soriano V, Benito JM. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia. J Antimicrob Chemoter. 2013;68:2616\u201325.","journal-title":"J Antimicrob Chemoter"},{"key":"151_CR54","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/JVI.75.14.6508-6516.2001","volume":"75","author":"JP Casazza","year":"2001","unstructured":"Casazza JP, Betts MR, Picker LJ, Koup RA. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol. 2001;75:6508\u201316.","journal-title":"J Virol"},{"key":"151_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2012.09.013","volume":"66","author":"S Serrano-Villar Serrano-Villar","year":"2013","unstructured":"Serrano-Villar Serrano-Villar S, Guti\u00e9rrez C, Vallejo A, Hern\u00e1ndez-Novoa B, D\u00edaz L, Abad Fern\u00e1ndez M, et al. The CD4\/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect. 2013;66:57\u201366.","journal-title":"J Infect"},{"key":"151_CR56","doi-asserted-by":"publisher","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","volume":"10","author":"S Serrano-Villar","year":"2014","unstructured":"Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, et al. HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathogens. 2014;10:e1004078.","journal-title":"PLoS Pathogens"},{"key":"151_CR57","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1189\/jlb.0410225","volume":"88","author":"E Brunetta","year":"2010","unstructured":"Brunetta E, Hudspeth KL, Mavilio D. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J Leukoc Biol. 2010;88:1119\u201330.","journal-title":"J Leukoc Biol"},{"key":"151_CR58","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/QAD.0b013e32835edc47","volume":"27","author":"S Pensieroso","year":"2013","unstructured":"Pensieroso S, Galli L, Nozza S, Ruffin N, Castagna A, Tambussi G, et al. B-cell subset alterations and correlated factors in HIV-1 infection. AIDS. 2013;27:1209\u201317.","journal-title":"AIDS"},{"key":"151_CR59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. 2003;9:727\u20138.","journal-title":"Nat Med"},{"key":"151_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/apc.2014.0173","volume":"29","author":"CT Costiniuk","year":"2015","unstructured":"Costiniuk CT, Jenabian MA. HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy. AIDS Patient Care STDs. 2015;29:55\u201368.","journal-title":"AIDS Patient Care STDs"},{"key":"151_CR61","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1128\/JVI.02482-10","volume":"85","author":"M Medina-Ram\u00edrez","year":"2011","unstructured":"Medina-Ram\u00edrez M, S\u00e1nchez-Merino V, S\u00e1nchez-Palomino S, Merino-Mansilla A, Ferreira CB, P\u00e9rez I, et al. Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia. J Virol. 2011;85:5804\u201313.","journal-title":"J Virol"},{"key":"151_CR62","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","volume":"104","author":"A S\u00e1ez-Ciri\u00f3n","year":"2007","unstructured":"S\u00e1ez-Ciri\u00f3n A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA. 2007;104:6776\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"151_CR63","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrmicro3352","volume":"12","author":"NM Archin","year":"2014","unstructured":"Archin NM, Sung JM, Garrido C, Soriano-Sarabia N, Margolis DM. Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat Rev Microbiol. 2014;12:750\u201364.","journal-title":"Nat Rev Microbiol"},{"key":"151_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2010.03259.x","volume":"130","author":"KK McKinstry","year":"2010","unstructured":"McKinstry KK, Strutt TM, Swain SL. The potential of CD4 T-cell memory. Immunology. 2010;130:1\u20139.","journal-title":"Immunology"},{"key":"151_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-065X.2010.00926.x","volume":"236","author":"W Cui","year":"2010","unstructured":"Cui W, Kaech SM. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev. 2010;236:151\u201366.","journal-title":"Immunol Rev"},{"key":"151_CR66","doi-asserted-by":"crossref","unstructured":"Hoxie JA, June CH. Novel cell and gene therapies for HIV. Cold Spring Harb Perspect Med. 2012; 2(10).","DOI":"10.1101\/cshperspect.a007179"},{"key":"151_CR67","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4161\/hv.19555","volume":"8","author":"F Garc\u00eda","year":"2012","unstructured":"Garc\u00eda F, Le\u00f3n A, Gatell JM, Plana M, Gallart T. Therapeutic vaccines against HIV infection. Hum Vaccin Immunother. 2012;8:569\u201381.","journal-title":"Hum Vaccin Immunother"},{"key":"151_CR68","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fimmu.2014.00417","volume":"5","author":"B Ensoli","year":"2014","unstructured":"Ensoli B, Cafaro A, Monini P, Marcotullio S, Ensoli F. Challenges in HIV Vaccine Research for Treatment and Prevention. Frontiers Immunol. 2014;5:417.","journal-title":"Frontiers Immunol"},{"key":"151_CR69","doi-asserted-by":"publisher","first-page":"a007054","DOI":"10.1101\/cshperspect.a007054","volume":"2","author":"B Walker","year":"2012","unstructured":"Walker B, McMichael A. The T-cell response to HIV. Cold Spring Harb Perspect Med. 2012;2:a007054.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"151_CR70","doi-asserted-by":"publisher","first-page":"a007070","DOI":"10.1101\/cshperspect.a007070","volume":"2","author":"M Carrington","year":"2012","unstructured":"Carrington M, Alter G. Innate immune control of HIV. Cold Spring Harb Perspect Med. 2012;2:a007070.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"151_CR71","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.iac.2009.04.012","volume":"29","author":"M Castells","year":"2009","unstructured":"Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am. 2009;29:585\u2013606.","journal-title":"Immunol Allergy Clin North Am"},{"key":"151_CR72","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1172\/JCI72061","volume":"124","author":"CA Keet","year":"2014","unstructured":"Keet CA, Wood RA. Emerging therapies for food allergy. J Clin Invest. 2014;124:1880\u20136.","journal-title":"J Clin Invest"},{"key":"151_CR73","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa043540","volume":"351","author":"RT Kenney","year":"2004","unstructured":"Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295\u2013301.","journal-title":"N Engl J Med"},{"key":"151_CR74","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","volume":"370","author":"I Leroux-Roels","year":"2007","unstructured":"Leroux-Roels I, Borkowski A, Vanwolleghem T, Dram\u00e9 M, Clement F, Hons E, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet. 2007;370:580\u20139.","journal-title":"Lancet"},{"key":"151_CR75","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nm0703-847","volume":"9","author":"M Pope","year":"2003","unstructured":"Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med. 2003;9:847\u201352.","journal-title":"Nat Med"},{"key":"151_CR76","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature08757","volume":"464","author":"A Haase","year":"2010","unstructured":"Haase A. Targeting early infection to prevent HIV-1 mucosal transmission. Nature. 2010;464:217\u201323.","journal-title":"Nature"},{"key":"151_CR77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-4690-6-51","volume":"6","author":"CM Coleman","year":"2009","unstructured":"Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology. 2009;6:51.","journal-title":"Retrovirology"},{"key":"151_CR78","first-page":"103","volume":"2","author":"NK Saksena","year":"2010","unstructured":"Saksena NK, Wang B, Zhou L, Soedjono M, Ho YS, Conceicao V. HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites. HIV\/AIDS (Auckl). 2010;2:103\u201322.","journal-title":"HIV\/AIDS (Auckl)"},{"key":"151_CR79","first-page":"13","volume":"13","author":"MD Iglesias-Ussel","year":"2011","unstructured":"Iglesias-Ussel MD, Romerio F. HIV reservoirs: the new frontier. AIDS Rev. 2011;13:13\u201329.","journal-title":"AIDS Rev"},{"key":"151_CR80","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5:512\u20137.","journal-title":"Nat Med"},{"key":"151_CR81","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/378412","volume":"188","author":"S Butt\u00f2","year":"2003","unstructured":"Butt\u00f2 S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, et al. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. J Infect Dis. 2003;188:1171\u201380.","journal-title":"J Infect Dis"},{"key":"151_CR82","unstructured":"Gregory TR. Animal Genome Size Database http:\/\/www.genomesize.com 2013."},{"key":"151_CR83","doi-asserted-by":"publisher","first-page":"e111919","DOI":"10.1371\/journal.pone.0111919","volume":"9","author":"A Casabianca","year":"2014","unstructured":"Casabianca A, Orlandi C, Canovari B, Scotti M, Acetoso M, Valentini M, et al. A real time PCR platform for the simultaneous quantification of total and extrachromosomal HIV DNA forms in blood of HIV-1 infected patients. PLoS ONE. 2014;9:e111919.","journal-title":"PLoS ONE"},{"key":"151_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.genom.7.080505.115700","volume":"7","author":"N Bannert","year":"2006","unstructured":"Bannert N, Kurth R. The evolutionary dynamics of Human Endogenous Retroviral families. Annu Rev Genomics Hum Genet. 2006;7:149\u201373.","journal-title":"Annu Rev Genomics Hum Genet"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-015-0151-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0151-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-015-0151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:08:57Z","timestamp":1651795737000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-015-0151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/s12977-015-0151-y","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]},"assertion":[{"value":"16 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}